James P Olsen1,2, Robert P Fellows1, Monica Rivera-Mindt1,3,2, Susan Morgello1,4, Desiree A Byrd1,3. 1. a Department of Neurology , The Icahn School of Medicine at Mount Sinai , New York , NY , USA. 2. c Department of Psychology , Fordham University , New York , NY , USA. 3. b Department of Psychiatry , The Icahn School of Medicine at Mount Sinai , New York , NY , USA. 4. d Department of Neuroscience , The Icahn School of Medicine at Mount Sinai , New York , NY , USA.
Abstract
UNLABELLED: The Wide Range Achievement Test, 3rd edition, Reading Recognition subtest (WRAT-3 RR) is an established measure of premorbid ability. Furthermore, its long-term reliability is not well documented, particularly in diverse populations with CNS-relevant disease. OBJECTIVE: We examined test-retest reliability of the WRAT-3 RR over time in an HIV+ sample of predominantly racial/ethnic minority adults. METHOD: Participants (N = 88) completed a comprehensive neuropsychological battery, including the WRAT-3 RR, on at least two separate study visits. Intraclass correlation coefficients (ICCs) were computed using scores from baseline and follow-up assessments to determine the test-retest reliability of the WRAT-3 RR across racial/ethnic groups and changes in medical (immunological) and clinical (neurocognitive) factors. Additionally, Fisher's Z tests were used to determine the significance of the differences between ICCs. RESULTS: The average test-retest interval was 58.7 months (SD = 36.4). The overall WRAT-3 RR test-retest reliability was high (r = .97, p < .001) and remained robust across all demographic, medical, and clinical variables (all r's > .92). ICCs did not differ significantly between the subgroups tested (all Fisher's Z p's > .05). CONCLUSIONS: Overall, this study supports the appropriateness of word-reading tests, such as the WRAT-3 RR, for use as stable premorbid IQ estimates among ethnically diverse groups. Moreover, this study supports the reliability of this measure in the context of change in health and neurocognitive status and in lengthy inter-test intervals. These findings offer strong rationale for reading as a "hold" test, even in the presence of a chronic, variable disease such as HIV.
UNLABELLED: The Wide Range Achievement Test, 3rd edition, Reading Recognition subtest (WRAT-3 RR) is an established measure of premorbid ability. Furthermore, its long-term reliability is not well documented, particularly in diverse populations with CNS-relevant disease. OBJECTIVE: We examined test-retest reliability of the WRAT-3 RR over time in an HIV+ sample of predominantly racial/ethnic minority adults. METHOD:Participants (N = 88) completed a comprehensive neuropsychological battery, including the WRAT-3 RR, on at least two separate study visits. Intraclass correlation coefficients (ICCs) were computed using scores from baseline and follow-up assessments to determine the test-retest reliability of the WRAT-3 RR across racial/ethnic groups and changes in medical (immunological) and clinical (neurocognitive) factors. Additionally, Fisher's Z tests were used to determine the significance of the differences between ICCs. RESULTS: The average test-retest interval was 58.7 months (SD = 36.4). The overall WRAT-3 RR test-retest reliability was high (r = .97, p < .001) and remained robust across all demographic, medical, and clinical variables (all r's > .92). ICCs did not differ significantly between the subgroups tested (all Fisher's Z p's > .05). CONCLUSIONS: Overall, this study supports the appropriateness of word-reading tests, such as the WRAT-3 RR, for use as stable premorbid IQ estimates among ethnically diverse groups. Moreover, this study supports the reliability of this measure in the context of change in health and neurocognitive status and in lengthy inter-test intervals. These findings offer strong rationale for reading as a "hold" test, even in the presence of a chronic, variable disease such as HIV.
Authors: Jennifer J Manly; Diane M Jacobs; Pegah Touradji; Scott A Small; Yaakov Stern Journal: J Int Neuropsychol Soc Date: 2002-03 Impact factor: 2.892
Authors: Lucette A Cysique; Donald Franklin; Ian Abramson; Ronald J Ellis; Scott Letendre; Ann Collier; David Clifford; Benjamin Gelman; Justin McArthur; Susan Morgello; David Simpson; J Allen McCutchan; Igor Grant; Robert K Heaton Journal: J Clin Exp Neuropsychol Date: 2011-03-07 Impact factor: 2.475
Authors: Michael C Diehr; Mariana Cherner; Tanya J Wolfson; S Walden Miller; Igor Grant; Robert K Heaton Journal: J Clin Exp Neuropsychol Date: 2003-06 Impact factor: 2.475
Authors: Peilin Jia; Zhongming Zhao; Todd Hulgan; William S Bush; David C Samuels; Cinnamon S Bloss; Robert K Heaton; Ronald J Ellis; Nicholas Schork; Christina M Marra; Ann C Collier; David B Clifford; Benjamin B Gelman; Ned Sacktor; Susan Morgello; David M Simpson; J Allen McCutchan; Jill S Barnholtz-Sloan; Donald R Franklin; Debralee Rosario; Scott L Letendre; Igor Grant; Asha R Kallianpur Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2017-04-26 Impact factor: 3.568
Authors: Laura M Campbell; Christine Fennema-Notestine; Rowan Saloner; Mariam Hussain; Anna Chen; Donald Franklin; Anya Umlauf; Ronald J Ellis; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Ned Sacktor; Susan Morgello; J Allen McCutchan; Scott Letendre; Igor Grant; Robert K Heaton Journal: J Int Neuropsychol Soc Date: 2019-10-02 Impact factor: 2.892
Authors: Rebecca L Koscik; Derek L Norton; Samantha L Allison; Erin M Jonaitis; Lindsay R Clark; Kimberly D Mueller; Bruce P Hermann; Corinne D Engelman; Carey E Gleason; Mark A Sager; Richard J Chappell; Sterling C Johnson Journal: J Int Neuropsychol Soc Date: 2018-12-07 Impact factor: 2.892
Authors: Tehila Eilam-Stock; Pamela Best; Kathleen Sherman; Michael T Shaw; Joseph Ventura; Lauren B Krupp; Leigh E Charvet Journal: Front Neurol Date: 2021-02-11 Impact factor: 4.003